Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24,017 | 26,293 | -13,787 | -37,386 | 880 |
| Depreciation Amortization | 1,881 | 1,421 | 946 | 479 | 2,011 |
| Income taxes - deferred | 40,801 | 42,547 | 14,775 | 670 | 68,090 |
| Accounts receivable | 35,148 | -38,475 | -4,282 | 42,118 | 47,236 |
| Other Working Capital | 39,650 | -33,814 | -8,607 | 50,075 | -819 |
| Other Operating Activity | -14,453 | 54,497 | 15,841 | -36,002 | -13,849 |
| Operating Cash Flow | $127,044 | $52,469 | $4,886 | $19,954 | $103,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | -35 | -33 | -31 | -142 |
| Investing Cash Flow | $-34 | $-35 | $-33 | $-31 | $-142 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 150,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -265,000 |
| Common Stock Issued | 216 | 94 | 94 | 6 | 11,013 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,983 |
| Financing Cash Flow | $216 | $94 | $94 | $6 | $-106,970 |
| Exchange Rate Effect | -329 | -680 | -654 | -7 | -32 |
| Beginning Cash Position | 88,559 | 88,559 | 88,559 | 88,559 | 92,154 |
| End Cash Position | 215,456 | 140,407 | 92,852 | 108,481 | 88,559 |
| Net Cash Flow | $126,897 | $51,848 | $4,293 | $19,922 | $-3,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | 127,044 | 52,469 | 4,886 | 19,954 | 103,549 |
| Capital Expenditure | -34 | -35 | -33 | -31 | -142 |
| Free Cash Flow | 127,010 | 52,434 | 4,853 | 19,923 | 103,407 |